Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Read

Showing results (671-680 of 718) with videos related to

Pageof 72
Sort By:
Genome Research|April 11, 2014
Predicting the virulence of MRSA from its genome sequenceMaisem Laabei, Mario Recker, Justine K Rudkin, et al.
Journal of Medicinal Chemistry|October 29, 2024
Rational Exploration of 2,4-Diaminopyrimidines as DHFR Inhibitors Active against <i>Mycobacterium abscessus</i> and <i>Mycobacterium avium</i>, Two Emerging Human PathogensMatheus Andrade Meirelles, Vitor M Almeida, Jaryd R Sullivan, et al.
Journal of Medicinal Chemistry|June 10, 2010
6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitorFabrizio Micheli, Paolo Cavanni, Daniele Andreotti, et al.
Journal of Medicinal Chemistry|August 23, 2016
Hit-to-Lead Optimization of a Novel Class of Potent, Broad-Spectrum TrypanosomacidesStephanie Russell, Raphaël Rahmani, Amy J Jones, et al.
Journal of Medicinal Chemistry|September 16, 2016
Discovery of a Quinoline-4-carboxamide Derivative with a Novel Mechanism of Action, Multistage Antimalarial Activity, and Potent in Vivo EfficacyBeatriz Baragaña, Neil R Norcross, Caroline Wilson, et al.
ACS Infectious Diseases|November 1, 2016
Biochemical and Structural Characterization of Selective Allosteric Inhibitors of the Plasmodium falciparum Drug Target, Prolyl-tRNA-synthetaseStephen Nakazawa Hewitt, David M Dranow, Benjamin G Horst, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 22, 2003
Complete genome sequence of the Q-fever pathogen Coxiella burnetiiRekha Seshadri, Ian T Paulsen, Jonathan A Eisen, et al.
RSC Medicinal Chemistry|January 22, 2021
Identification of 6-amino-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidines with <i>in vivo</i> efficacy against visceral leishmaniasisMichael G Thomas, Manu De Rycker, Myriam Ajakane, et al.
Journal of Medicinal Chemistry|March 18, 2022
Repositioning of a Diaminothiazole Series Confirmed to Target the Cyclin-Dependent Kinase CRK12 for Use in the Treatment of African Animal TrypanosomiasisAlasdair Smith, Richard J Wall, Stephen Patterson, et al.
Plos One|April 6, 2011
Genomic signatures of strain selection and enhancement in Bacillus atrophaeus var. globigii, a historical biowarfare simulantHenry S Gibbons, Stacey M Broomall, Lauren A McNew, et al.
Pageof 72

Showing results (671-680 of 718) with videos related to

Sort By:
Pageof 72
Genome Research|April 11, 2014
Predicting the virulence of MRSA from its genome sequenceMaisem Laabei, Mario Recker, Justine K Rudkin, et al.
Journal of Medicinal Chemistry|October 29, 2024
Rational Exploration of 2,4-Diaminopyrimidines as DHFR Inhibitors Active against <i>Mycobacterium abscessus</i> and <i>Mycobacterium avium</i>, Two Emerging Human PathogensMatheus Andrade Meirelles, Vitor M Almeida, Jaryd R Sullivan, et al.
Journal of Medicinal Chemistry|June 10, 2010
6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitorFabrizio Micheli, Paolo Cavanni, Daniele Andreotti, et al.
Journal of Medicinal Chemistry|August 23, 2016
Hit-to-Lead Optimization of a Novel Class of Potent, Broad-Spectrum TrypanosomacidesStephanie Russell, Raphaël Rahmani, Amy J Jones, et al.
Journal of Medicinal Chemistry|September 16, 2016
Discovery of a Quinoline-4-carboxamide Derivative with a Novel Mechanism of Action, Multistage Antimalarial Activity, and Potent in Vivo EfficacyBeatriz Baragaña, Neil R Norcross, Caroline Wilson, et al.
ACS Infectious Diseases|November 1, 2016
Biochemical and Structural Characterization of Selective Allosteric Inhibitors of the Plasmodium falciparum Drug Target, Prolyl-tRNA-synthetaseStephen Nakazawa Hewitt, David M Dranow, Benjamin G Horst, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 22, 2003
Complete genome sequence of the Q-fever pathogen Coxiella burnetiiRekha Seshadri, Ian T Paulsen, Jonathan A Eisen, et al.
RSC Medicinal Chemistry|January 22, 2021
Identification of 6-amino-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidines with <i>in vivo</i> efficacy against visceral leishmaniasisMichael G Thomas, Manu De Rycker, Myriam Ajakane, et al.
Journal of Medicinal Chemistry|March 18, 2022
Repositioning of a Diaminothiazole Series Confirmed to Target the Cyclin-Dependent Kinase CRK12 for Use in the Treatment of African Animal TrypanosomiasisAlasdair Smith, Richard J Wall, Stephen Patterson, et al.
Plos One|April 6, 2011
Genomic signatures of strain selection and enhancement in Bacillus atrophaeus var. globigii, a historical biowarfare simulantHenry S Gibbons, Stacey M Broomall, Lauren A McNew, et al.
Pageof 72